MDMichel Doumith

Michel Doumith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michel Doumith has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Matthew J. Ellington

    Cambridge Microbiology and Public Health Laboratory , HPA—Addenbrooke's Hospital , Hills Road, Cambridge CB2 0QW , UK

    2 shared publications
  • Neil Woodford

    Antibiotic Resistance Monitoring & Reference Laboratory , HPA—Colindale , 61 Colindale Avenue, London NW9 5EQ , UK

    2 shared publications
  • David M. Livermore

    Antibiotic Resistance Monitoring and Reference Laboratory , Health Protection Agency, Centre for Infections , 61 Colindale Avenue, London NW9 5EQ , UK

    1 shared publication
  • Hiran Dhanji

    Antibiotic Resistance Monitoring & Reference Laboratory , HPA—Colindale , 61 Colindale Avenue, London NW9 5EQ , UK

    1 shared publication
  • John Wain

    Microbes and Food Safety, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, United Kingdom

    1 shared publication
  • M. J. Day

    Microbiology Services-Colindale, Health Protection Agency, London, United Kingdom

    1 shared publication

Latest Publications

  • Improved Multiplex PCR Strategy for Rapid Assignment of the Four Major Escherichia coli Phylogenetic Groups

    by M. Doumith, M. J. Day, R. Hope, J. Wain, N. Woodford

    Using data from whole-genome projects, an updated multiplex PCR strategy was developed to assign Escherichia coli isolates rapidly to major phylogenetic groups. This assay accommodates sequence variations detected within target sequences, thereby increasing sensitivity and reliability. It was validated using 185 isolates of known sequence types and showed improved congruence with multilocus sequence typing data.


  • Open Access

    Characterization of plasmids encoding extended-spectrum -lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK

    by Michel Doumith, Hiran Dhanji, Matthew J. Ellington, Peter Hawkey, Neil Woodford

    To characterize plasmids encoding extended-spectrum β-lactamases (ESBLs) from a recent UK collection of clinical Escherichia coli isolates. The isolates comprised 118 ESBL producers referred from 54 laboratories. Plasmids were transferred by electroporation, and their incompatibility groups, associated addiction systems and resistance genes with the flanking genetic environments were identified by PCR or sequencing. Seventy isolates had plasmids encoding CTX-M-15 (n = 53), CTX-M-14 (n = 9), CTX-M-27 (n = 1), CTX-M-3 (n = 2) and SHV-12 (n = 5) ESBLs that were transformable; non-transformable ESBLs were mainly CTX-M enzymes (42/48). Most transformable blaCTX-M-15 genes (43/53) were harboured on single replicon or multireplicon IncF plasmids, with IncFIA4-FIB1-FII31 (n = 11) and IncFIA1-FII2 (n = 15) being most frequent; the latter included eight pEK499 plasmids, typical of UK epidemic strain A. Plasmids harbouring blaCTX-M-14 belonged variously to IncF, IncI1 and IncHI2 types, and 16 encoding CTX-M or SHV enzymes were non-typeable. Only IncF plasmid types carried the addiction systems sought and those with blaCTX-M-15 frequently harboured blaOXA-1 and aac(6′)-Ib-cr, and often transferred trimethoprim and tetracycline resistance; those with blaCTX-M-14 encoded trimethoprim, sulphonamide, streptomycin and tetracycline resistance. Most ESBL genes were associated with the well-known mobile elements ISEcp1 and IS26, but nearly half (23/55) of the ISEcp1 sequences upstream of blaCTX-M-15 were interrupted by an IS26 at various positions. Most ESBLs (70/118) were encoded by transformable plasmids, although a sizable minority could not be transformed. The majority of transformable plasmids (51/70; 72.9%) were diverse multiresistant IncF types possessing multiple addiction systems. The spread of blaCTX-M-15 can be attributed not just to clonal expansion, but also to the horizontal dissemination of related plasmids.


  • Open Access

    Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

    by Michel Doumith, Matthew J. Ellington, David M. Livermore, Neil Woodford

    The aim of this study was to investigate relatedness and molecular mechanism(s) of ertapenem resistance in clinical isolates of Klebsiella spp. (n = 28) and Enterobacter spp. (n = 27) referred from multiple hospitals to the UK national reference laboratory. Investigations included genotyping by PFGE, resistance gene analysis by PCR and antimicrobial susceptibility testing with and without inhibitors of efflux and β-lactamase activity. Outer membrane proteins (OMPs) were profiled by SDS–PAGE; porin genes were sequenced and their expression was examined by RT–PCR. The contribution of porin deficiency to resistance was investigated by restoring functional porin genes on plasmids. PFGE showed significant clonal diversity among ertapenem-resistant isolates, with only small clusters identified. SHV- and CTX-M-type extended-spectrum β-lactamases were identified in the Klebsiella spp. isolates, whereas AmpC overexpression or KPC carbapenemase was detected in the Enterobacter cloacae isolates. SDS–PAGE showed that Klebsiella pneumoniae and Enterobacter aerogenes with high-level ertapenem resistance (MICs ≥ 16 mg/L) consistently lacked both of the two major non-specific porins, whereas variable patterns of OmpC and OmpF were seen in E. cloacae with lower-level ertapenem resistance. Various point mutations or insertion sequences were identified as disrupting the porin-coding sequences, as well as mutations in the promoter region. Functional restoration of OmpK35 or OmpK36 in Klebsiella and OmpC or OmpF in Enterobacter spp. isolates significantly decreased the MICs of all carbapenems, but particularly of ertapenem. We found no evidence of efflux contributing to resistance. Ertapenem resistance was exclusively due to combinations of β-lactamases with impermeability caused by loss of OMPs. Efflux was not implicated and there was no national spread of resistant clones.